E. Bonizzoni

431 total citations
12 papers, 245 citations indexed

About

E. Bonizzoni is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, E. Bonizzoni has authored 12 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Molecular Biology. Recurrent topics in E. Bonizzoni's work include Nausea and vomiting management (3 papers), Adenosine and Purinergic Signaling (2 papers) and Diabetes and associated disorders (2 papers). E. Bonizzoni is often cited by papers focused on Nausea and vomiting management (3 papers), Adenosine and Purinergic Signaling (2 papers) and Diabetes and associated disorders (2 papers). E. Bonizzoni collaborates with scholars based in Italy and Spain. E. Bonizzoni's co-authors include E. Ongini, Silvano Milani, C Casati, Angela Monopoli, Silvio Dionisotti, Cristina Zocchi, Gualberto Gussoni, Giovanni Scanelli, Ido Iori and Antonio Ceriello and has published in prestigious journals such as Diabetes, European Heart Journal and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

E. Bonizzoni

12 papers receiving 237 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Bonizzoni Italy 7 65 58 51 38 37 12 245
Hisakatsu Ito Japan 9 49 0.8× 52 0.9× 99 1.9× 4 0.1× 4 0.1× 25 288
Juan Ji China 6 34 0.5× 32 0.6× 11 0.2× 22 0.6× 17 0.5× 11 370
Robert J. Theobald United States 11 24 0.4× 52 0.9× 6 0.1× 18 0.5× 77 2.1× 23 372
Birgit Houweling Netherlands 11 256 3.9× 51 0.9× 76 1.5× 23 0.6× 3 0.1× 14 454
A. Lieberman United States 12 59 0.9× 34 0.6× 73 1.4× 39 1.0× 4 0.1× 18 579
Patrik Aronsson Sweden 12 15 0.2× 23 0.4× 4 0.1× 21 0.6× 42 1.1× 43 349
K. Wild Germany 9 75 1.2× 37 0.6× 7 0.1× 6 0.2× 12 0.3× 16 331
Marc Hofmann Germany 8 76 1.2× 44 0.8× 71 1.4× 19 0.5× 14 336
Cinzia Simoni Italy 11 118 1.8× 43 0.7× 11 0.2× 48 1.3× 15 250
Pierre‐Paul van Bogaert Belgium 11 61 0.9× 33 0.6× 8 0.2× 24 0.6× 7 0.2× 15 321

Countries citing papers authored by E. Bonizzoni

Since Specialization
Citations

This map shows the geographic impact of E. Bonizzoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Bonizzoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Bonizzoni more than expected).

Fields of papers citing papers by E. Bonizzoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Bonizzoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Bonizzoni. The network helps show where E. Bonizzoni may publish in the future.

Co-authorship network of co-authors of E. Bonizzoni

This figure shows the co-authorship network connecting the top 25 collaborators of E. Bonizzoni. A scholar is included among the top collaborators of E. Bonizzoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Bonizzoni. E. Bonizzoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Celio, Luigi, Diego Cortinovis, Luigi Cavanna, et al.. (2020). 1815MO Two simplified dexamethasone (DEX)-sparing regimens with NEPA for the prevention of emesis caused by cisplatin (DDP): A phase III, controlled, non-inferiority trial. Annals of Oncology. 31. S1048–S1048. 1 indexed citations
2.
Borzı̀, Vito, Stefania Frasson, Gualberto Gussoni, et al.. (2016). Risk factors for hypoglycemia in patients with type 2 diabetes, hospitalized in internal medicine wards: Findings from the FADOI-DIAMOND study. Diabetes Research and Clinical Practice. 115. 24–30. 30 indexed citations
3.
Bosi, Emanuele, Marina Scavini, Antonio Ceriello, et al.. (2012). Structured SMBG improve Hba1c through targeted changes in diabetes therapy in patients with non–insulin treated type 2 diabetes: the PRISMA Study.. Diabetes. 61. 2 indexed citations
4.
Longo, Flavia, et al.. (2012). Combination of aprepitant, palonosetron and dexamethasone as antiemetic prophylaxis in lung cancer patients receiving multiple cycles of cisplatin‐based chemotherapy. International Journal of Clinical Practice. 66(8). 753–757. 30 indexed citations
5.
Gussoni, Gualberto, Ido Iori, Roberto Nardi, et al.. (2011). Clinical profile and predictors of in-hospital outcome in patients with heart failure: The FADOI “CONFINE” Study. International Journal of Cardiology. 152(1). 88–94. 35 indexed citations
6.
7.
Menozzi, Alberto, Emilia Solinas, Alessandra Repetto, et al.. (2009). Twenty-four months clinical outcomes of sirolimus-eluting stents for the treatment of small coronary arteries: the long-term SES-SMART clinical study. European Heart Journal. 30(17). 2095–2101. 24 indexed citations
8.
Chieffo, Alaide, Goran Stanković, & E. Bonizzoni. (2005). Early and Mid-Term Results of Drug-Eluting Stent Implantation in Unprotected Left Main. ACC Current Journal Review. 14(6). 25–25. 3 indexed citations
9.
Agnelli, Giancarlo, Giorgio Bolis, Lorenzo Capussotti, et al.. (2003). A clinical outcome-based prospective study on venous thromboembolism in cancer surgery: the @RISTOS project. Journal of Thrombosis and Haemostasis. 1. OC191–OC191. 1 indexed citations
10.
Casati, C, Angela Monopoli, A Forlani, E. Bonizzoni, & E. Ongini. (1995). Telemetry monitoring of hemodynamic effects induced over time by adenosine agonists in spontaneously hypertensive rats.. Journal of Pharmacology and Experimental Therapeutics. 275(2). 914–919. 16 indexed citations
11.
Casati, C, Angela Monopoli, Silvio Dionisotti, et al.. (1994). Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.. Journal of Pharmacology and Experimental Therapeutics. 268(3). 1506–1511. 33 indexed citations
12.
Ongini, E., et al.. (1993). Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat.. Journal of Pharmacology and Experimental Therapeutics. 266(2). 726–731. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hisakatsu Ito Breakdown of academic impact, for papers by Juan Ji Breakdown of academic impact, for papers by Robert J. Theobald Breakdown of academic impact, for papers by Birgit Houweling Breakdown of academic impact, for papers by A. Lieberman Breakdown of academic impact, for papers by Patrik Aronsson Breakdown of academic impact, for papers by K. Wild Breakdown of academic impact, for papers by Marc Hofmann Breakdown of academic impact, for papers by Cinzia Simoni Breakdown of academic impact, for papers by Pierre‐Paul van Bogaert
Rankless by CCL
2026